Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Ruberg FL, Maurer MS.
JAMA. 2024 Mar 5;331(9):778-791. doi: 10.1001/jama.2024.0442.
PMID:38441582
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation.
Thompson AD, Helms AS, Kannan A, Yob J, Lakdawala NK, Wittekind SG, Pereira AC, Jacoby DL, Colan SD, Ashley EA, Saberi S, Ware JS, Ingles J, Semsarian C, Michels M, Mazzarotto F, Olivotto I, Ho CY, Day SM.
Genet Med. 2021 Jul;23(7):1281-1287. doi: 10.1038/s41436-021-01134-9. Epub 2021 Mar 29.
PMID:33782553
Prediction of Ischemic Stroke Functional Outcomes from Acute-Phase Noncontrast CT and Clinical Information.
Liu Y, Yu Y, Ouyang J, Jiang B, Ostmeier S, Wang J, Lu-Liang S, Yang Y, Yang G, Michel P, Liebeskind DS, Lansberg M, Moseley ME, Heit JJ, Wintermark M, Albers G, Zaharchuk G.
2020 Aug 13. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025.
PMID:32790266
Prevalence of Right Atrial Impairment and Association with Outcomes in Cardiac Amyloidosis.
Singulane CC, Slivnick JA, Addetia K, Asch FM, Sarswat N, Soulat-Dufour L, Mor-Avi V, Lang RM.